Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Rumeysa Çolak"'
Autor:
Ezgi Değerli, İlkay Gültürk, Rumeysa Çolak, Caner Kapar, Ayşe Gül Satman Durmaz, Esra Turan Canbaz, Mahmut Said Değerli, Mesut Yılmaz
Publikováno v:
İstanbul Medical Journal, Vol 25, Iss 4, Pp 336-340 (2024)
Introduction: Adjuvant chemotherapy, particularly oral capecitabine, is often considered for stage 2 colon cancer despite its controversial use in elderly patients with comorbidities. This study aimed to assess the toxicity, tolerability, and surviva
Externí odkaz:
https://doaj.org/article/02df79dec6784ad6a515e0c9c3cba05f
Publikováno v:
Kastamonu Medical Journal. :39-43
Aim: Coronavirus disease is the third coronavirus infection defined in the world in the 21st century, after severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS).Material and Method: We planned to evaluate demographic c
Autor:
Ezgi Degerli, Mesut Yilmaz, Gulcin Sahingoz Erdal, Rumeysa Colak, Caner Kapar, Ayse Gul Satman Durmaz, Esra Turan Canbaz, Deniz Tural
Publikováno v:
Haseki Tıp Bülteni, Vol 62, Iss 4, Pp 229-234 (2024)
Aim: Immune checkpoint inhibitors have transformed cancer treatment; however, clinical trials often exclude patients with renal dysfunction. This study aimed to evaluate the efficacy and safety of nivolumab in this population, addressing the limited
Externí odkaz:
https://doaj.org/article/e0b796dbbcca44f3aa2c3e1bb6a9ed9c
Publikováno v:
Breast, Vol 78, Iss , Pp 103820- (2024)
Introduction: Cyclin Dependent Kinase (CDK) 4–6 inhibitors are the recommended first-line treatment option for hormone-positive metastatic breast cancer (MBC). They show their effects by causing cell cycle arrest in G1-S phase. Neutropenia is the m
Externí odkaz:
https://doaj.org/article/8def638d33f74f029489758c3809c2f4